SG3 Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

SG3 Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,500	Closed	-$68K	–	372
2016 Q4	$68K	Buy	+5,500	New	+$66.2K	0.01%	221

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

SG3 Management's ARIA Position: Q1 2017 in Review

SG3 Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 5,500 shares — an estimated $68K sold.

SG3 Management first reported a position in ARIA in Q4 2016 and held it in 1 quarter. The position peaked at $68K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

SG3 Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
SG3 Management sold 5,500 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $68K.
SG3 Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
SG3 Management's Ariad Pharmaceuticals Inc position peaked at $68K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on SG3 Management's 13F filing for Q1 2017, filed 25 Jan 2018.